{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:29:22Z","timestamp":1784334562852,"version":"3.55.0"},"reference-count":26,"publisher":"Impact Journals, LLC","issue":"41","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,10,11]]},"DOI":"10.18632\/oncotarget.11484","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T20:29:37Z","timestamp":1471897777000},"page":"66769-66775","source":"Crossref","is-referenced-by-count":7,"title":["New therapy with ASC-J9\u00ae to suppress the prostatitis<i>via<\/i>altering the cytokine CCL2 signals"],"prefix":"10.18632","volume":"7","author":[{"given":"Shin-Jen","family":"Lin","sequence":"first","affiliation":[{"name":"George Whipple Laboratory for Cancer Research, Departments of Pathology, Urology, and Radiation Oncology, and Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY 14642, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Ju","family":"Chou","sequence":"additional","affiliation":[{"name":"George Whipple Laboratory for Cancer Research, Departments of Pathology, Urology, and Radiation Oncology, and Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY 14642, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Yi","family":"Lin","sequence":"additional","affiliation":[{"name":"George Whipple Laboratory for Cancer Research, Departments of Pathology, Urology, and Radiation Oncology, and Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY 14642, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Chiang","family":"Chang","sequence":"additional","affiliation":[{"name":"George Whipple Laboratory for Cancer Research, Departments of Pathology, Urology, and Radiation Oncology, and Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY 14642, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyuan","family":"Yeh","sequence":"additional","affiliation":[{"name":"George Whipple Laboratory for Cancer Research, Departments of Pathology, Urology, and Radiation Oncology, and Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY 14642, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chawnshang","family":"Chang","sequence":"additional","affiliation":[{"name":"George Whipple Laboratory for Cancer Research, Departments of Pathology, Urology, and Radiation Oncology, and Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY 14642, USA"},{"name":"Sex Hormone Research Center, China Medical University\/Hospital, Taichung 404, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,8,22]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0022-5347(01)63564-X","article-title":"How common is prostatitis? A national survey of physician visits","volume":"159","author":"Barry","year":"1998","journal-title":"J Urol"},{"key":"2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jama.282.3.236","article-title":"NIH consensus definition and classification of prostatitis","volume":"282","author":"Nickel","year":"1999","journal-title":"Jama"},{"key":"3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev.med.57.011205.135654","article-title":"Prostatitis\/chronic pelvic pain syndrome","volume":"57","author":"Schaeffer","year":"2006","journal-title":"Ann Rev Med"},{"key":"4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/01.ju.0000136002.76898.04","article-title":"Mechanisms in prostatitis\/chronic pelvic pain syndrome","volume":"172","author":"Ruggieri","year":"2004","journal-title":"J Urol"},{"key":"5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0090-4295(97)00456-1","article-title":"Autoimmune prostatitis: evidence of T cell reactivity with normal prostatic proteins","volume":"50","author":"Ponniah","year":"1997","journal-title":"Urology"},{"key":"6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-0897.1984.tb00281.x","article-title":"Experimental autoimmune damage to rat male accessory glands. II. T cell requirement in adoptive transfer of specific tissue damage","volume":"5","author":"Casadio","year":"1984","journal-title":"Am J Reprod Immunol"},{"key":"7","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/j.1939-4640.2000.tb02135.x","article-title":"Oxidative stress in prostatic fluid of patients with chronic pelvic pain syndrome: correlation with gram positive bacterial growth and treatment response","volume":"21","author":"Shoskes","year":"2000","journal-title":"J Androl"},{"key":"8","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1365-2249.2002.01853.x","article-title":"Autoimmune T cell responses to seminal plasma in chronic pelvic pain syndrome (CPPS)","volume":"128","author":"Gaston","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/1097-0045(20000615)44:1<49::AID-PROS7>3.0.CO;2-7","article-title":"PSA is a candidate self-antigen in autoimmune chronic prostatitis\/chronic pelvic pain syndrome","volume":"44","author":"Alexander","year":"2000","journal-title":"The Prostate"},{"key":"10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0145-305X(99)00088-9","article-title":"Changes in the development of experimental autoimmune prostatitis (EAP) by castration in aged rats","volume":"24","author":"Pistoresi-Palencia","year":"2000","journal-title":"Dev Com Immunol"},{"key":"11","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.4049\/jimmunol.179.3.1559","article-title":"Spontaneous and prostatic steroid binding protein peptide-induced autoimmune prostatitis in the nonobese diabetic mouse","volume":"179","author":"Ad orini","year":"2007","journal-title":"J Immunol"},{"key":"12","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nm1547","article-title":"ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor","volume":"13","author":"Chang","year":"2007","journal-title":"Nat Med"},{"key":"13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1593\/neo.111436","article-title":"ASC-J9 suppresses castration-resistant prostate cancer growth through degradation of full-length and splice variant androgen receptors","volume":"14","author":"Chang","year":"2012","journal-title":"Neoplasia"},{"key":"14","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ajpath.2012.10.029","article-title":"New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells","volume":"182","author":"Chang","year":"2013","journal-title":"The American journal of pathology"},{"key":"15","doi-asserted-by":"crossref","first-page":"e764","DOI":"10.1038\/cddis.2013.270","article-title":"Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling","volume":"4","author":"Chang","year":"2013","journal-title":"Cell Death & Dis"},{"key":"16","doi-asserted-by":"crossref","first-page":"19359","DOI":"10.1074\/jbc.M113.477216","article-title":"Differential androgen deprivation therapies with anti-androgens casodex\/bicalutamide or MDV3100\/Enzalutamide versus anti-androgen receptor ASC-J9(R) Lead to promotion versus suppression of prostate cancer metastasis","volume":"288","author":"Chang","year":"2013","journal-title":"J Biol Chem"},{"key":"17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jpba.2013.08.020","article-title":"Determination of androgen receptor degradation enhancer ASC-J9((R)) in mouse sera and organs with liquid chromatography tandem mass spectrometry","volume":"88","author":"Chang","year":"2014","journal-title":"J Pharm Biomed Anal"},{"key":"18","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1172\/JCI39335","article-title":"Monocyte\/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-alpha expression","volume":"119","author":"Chang","year":"2009","journal-title":"J Clin Invest"},{"key":"19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1210\/me.2012-1244","article-title":"Targeting thymic epithelia AR enhances T-cell reconstitution and bone marrow transplant grafting efficacy","volume":"27","author":"Chang","year":"2013","journal-title":"Mol Endocrinol"},{"key":"20","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/emmm.201202367","article-title":"Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2\/CCR2-induced STAT3 activation","volume":"5","author":"Chang","year":"2013","journal-title":"EMBO Mol Med"},{"key":"21","doi-asserted-by":"crossref","first-page":"R580","DOI":"10.1152\/ajpregu.00240.2012","article-title":"CCL2 and CCL3 are essential mediators of pelvic pain in experimental autoimmune prostatitis","volume":"303","author":"Thumbikat","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"22","first-page":"3282","article-title":"Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer","volume":"6","author":"Matsushima","year":"2000","journal-title":"Clin Cancer Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0165-2478(99)00043-7","article-title":"MCP-1 expression as a potential contributor to the high malignancy phenotype of murine mammary adenocarcinoma cells","volume":"68","author":"Ben-Baruch","year":"1999","journal-title":"Immunol Lett"},{"key":"24","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1128\/MCB.11.6.3125","article-title":"Suppression of tumor formationby expression of the JE gene in malignant cells","volume":"11","author":"Sunday","year":"1991","journal-title":"Mol Cell Biol"},{"key":"25","first-page":"231","article-title":"Expression of the JE\/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells","volume":"39","author":"Bar-Eli","year":"1994","journal-title":"Cancer Immunol Immunother"},{"key":"26","first-page":"7002","article-title":"Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice","volume":"60","author":"Sone","year":"2000","journal-title":"Cancer Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:34:33Z","timestamp":1718757273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,22]]},"references-count":26,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2016,10,11]]}},"alternative-id":["11484","27564257"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.11484","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,22]]}}}